Reprieve Cardiovascular: Improving the Front-Line Therapy for Acute Decompensated HF

article image

Reprieve Cardiovascular’s Guided Diuretic Therapy for fluid overload optimizes diuretics, today’s front line therapy for acute decompensated heart failure, in a way that promises to be faster, safer, and, in the long run, more helpful for patient management than drugs on their own.

Reprieve Cardiovascular Inc. was launched just five months ago to address the leading cause of hospital admissions among older patients: acute decompensated heart failure (ADHF). In the US, one million patients with ADHF end up in the hospital each year.


This article is restricted to subscribers only.

Sign in to continue reading.


We're here to help! Please contact us at: